Parvin Aminolroaya of Seeger Weiss – Courtesy photo

Parvin Aminolroaya is a partner at Seeger Weiss.

What do you see as your biggest accomplishments over the past two years, and why?

In re National Prescription Opiate Litigation is one of the most significant cases I've worked on over the last two years. My work typically focuses on large-scale multidistrict litigation, and, in this one, the stakes are enormous. A crucial part of my work in this litigation over the past two years has been identifying a causative link between drug manufacturers' marketing practices and an increased risk of opioid abuse, which has shattered communities across the country. In particular, I worked with one leading regulatory expert who found that these promotional practices deviated from Federal Drug Administration standards. It is key to the larger argument we're making in the case.